The pharmaceutical industry
Baden-Württemberg is Germany’s largest pharma location. In addition to industry giants such as Roche, GlaxoSmithKline and Boehringer Ingelheim, Baden-Württemberg is home to a large number of small- and medium-sized pharmaceutical companies and biotech companies with pharmaceutical R&D. According to the Baden-Württemberg Statistics Office, one in four employees in the pharmaceutical industry work in Baden-Württemberg.
The pharmaceutical industry continues to be a recession-proof employer and is very loyal to Baden-Württemberg. According to BIOPRO 126 pharmaceutical companies are located in Baden-Württemberg. Of them, 46 companies are pure distributors, suppliers or plant manufacturers. 80 of the 126 pharmaceutical companies carry out research, development and/or manufacture in Baden-Württemberg. The Baden-Württemberg Statistics Office has been able to acquire key figures for 2013 for all of the 80 companies:
- The companies had 18,549 employees and generated taxable revenues of 6.16 billion euros
- 64 companies (80 %) had less than 250 employees.
-
Around two thirds of revenue (4.49 billion euros) was generated by the 16 companies with more than 250 employees.
-
The 2014 export rate was 70.2 percent (figures based on companies with more than 20 employees).
-
In 2014, the companies produced pharmaceutical products worth 3.93 billion euros.
-
Most pharmaceutical companies are located in the Stuttgart region (15) and in the central and southern Upper Rhine regions (14 each).
Danube-Iller and Rhine-Neckar are the two regions with the highest revenues. Companies in the Danube-Iller region generated 36 % of overall revenues and companies in the Rhine-Neckar region, 18 %.
